Tisch MS News

American Academy of Neurology Update - Wednesday, April 30th

The Tisch MS research center presented several more posters at the Philadelphia AAN meeting, including: Cerebrospinal Fluid Mononuclear Phagocytes Are Decreased In Number and Express Less IL-10 In Multiple Sclerosis Compared To Values Seen With Normal Controls Shivani Agarwal, Irene Jarchum, Ying...

May 2, 2014

More

AAN Special Session

The study summarized in these four slides was selected for a special session at the AAN entitled “Multiple Sclerosis: Highlights in the Field”. Of the 600+ abstracts submitted to the AAN, 35 were selected to be highlighted in this session as representative of important advances in the field. The...

May 2, 2014

More

AAN News - Estriol Study

By Dr. James W. Stark A study presented at the AAN examined the use of estriol in combination with copaxone in the treatment of 158 relapsing-remitting MS patients. At 12 months, the group treated with both copaxone and estriol had improved relapse rates, however that effect was less apparent at 24...

May 1, 2014

More

American Academy of Neurology Review 4/28 & 4/29

Tuesday, April 29th Today’s Tisch MS Center poster presentations included: Transient Neurologic Worsening after Initiation of Dimethyl Fumarate Therapy in Progressive Multiple Sclerosis Patients James W Stark, Sydney Chirls, Saud Sadiq Summary: We identified 18 patients with progressive forms of MS...

May 1, 2014

More

Research from Tisch MSRCNY Selected as Highlight at AAN

We are pleased to announce the stem cell research from Tisch MSRCNY has been selected to be presented as a highlight during the Annual Meeting of the American Academy of Neurology. This will take place later today during the portion of the Meeting pertaining to MS. We will provide an update for you...

April 30, 2014

More

Tisch MS Research Center of New York Exceeds $300K Crowdfunding Target for FDA-Approved Stem Cell Trial

Please read our press release on the success of the Tisch MSRCNY Phase I Clinical Stem Cell Trial campaign on Indiegogo.com. To continue to support this important initiative CLICK HERE . We are truly grateful to everyone who is helping to fund our mission to repair the damage caused by multiple...

April 15, 2014

More

Stem Cell Trial Update: March 17, 2014

Tisch MS Research Center of New York is delighted to announce that it has received regulatory approval needed to commence our proposed phase I clinical trial of mesenchymal stem cell-derived neural progenitor cells for the treatment of progressive multiple sclerosis. Patient enrollment and the...

March 17, 2014

More

Stem Cell Trial Update:February 27, 2014

Tisch MS Research Center of New York continues to be in active deliberation with an Institutional Review Board regarding approval of our stem cell clinical trial. We expect to have all outstanding concerns addressed in the near future and will begin study activities at that time. Please note that...

February 27, 2014

More

Stem Cell Trial Update: January 31, 2014

Tisch MS Research Center of New York submitted our FDA-approved protocol for review by an Institutional Review Board (IRB), an organization designated by the Department of Health and Human Services (HHS) to monitor and supervise research involving human subjects, whose approval is a regulatory...

January 31, 2014

More

12 Posters Accepted to the 2014 American Academy of Neurology Meeting

The Tisch MS Research Center has had twelve scientific research presentations accepted to the 66 th annual meeting of the American Academy of Neurology. The conference is the largest gathering of the neurological community in the world and will take place at the end of April in Philadelphia. Twelve...

January 28, 2014

More

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.